Italian Sarcoma Group
Dott. Piero Picci
Sarcomas are rare neoplasms requiring multidisciplinary treatment, including orthopedists, surgeons, oncologists, pathologists, radiologists, radiotherapists, and basic researchers.
On this basis, several specialists in treating sarcomas needed to come together to improve the treatment of these cancers.
In June 1997, the Italian Sarcoma Group was founded to further improve the quality of sarcoma treatment by promoting knowledge in this field and prepare and implement multicentric therapeutic and research protocols.
The main activity of ISG is in developing clinical trials and spontaneous observational studies, national and international, in the field of both bone and soft tissue sarcomas. As part of its main activity, it proposes training projects in clinical research to participate in clinical studies promoted by ISG.
Since July 2007, ISG has been a member of the Alliance Against Cancer. It has collaborated in projects such as the Extraordinary Oncology Programme 2006 by creating the National Network for the treatment and research of musculoskeletal sarcomas.
Italian Sarcoma Group is also engaged in advocacy activities, providing support and coordination to patient associations operating in sarcomas, thus establishing an essential network with patients, with the ultimate aim of improving the treatment and quality of life of patients with sarcomas.
Since 2005, more than 20 interventional clinical trials for the treatment of sarcomas and an equal number of observational studies have been initiated and conducted within the framework of European projects, offering sarcoma patients the possibility of benefiting from increasingly innovative therapies and therapeutic approaches.
ISG actively collaborates with the major international cooperative groups dealing with the treatment of sarcomas and, as a national network for the treatment of sarcomas, is involved in the major European projects dedicated to this disease, Eurosarc and Euroewing.
Since its creation in April 2015, ISG has been a member of FICOG (Federation of Italian Clinical Oncology Groups), whose aim is to promote and contribute to oncological research from the clinical and experimental perspective as well as develop and promote clinical trials.
The entire ISG ac
Consult the individual files of our Members